| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/13/2023 | 267.67% | HC Wainwright & Co. | $15 → $5 | Maintains | Buy |
| 08/16/2023 | 1003.02% | HC Wainwright & Co. | → $15 | Reiterates | Buy → Buy |
| 06/29/2023 | 1003.02% | HC Wainwright & Co. | $15 → $15 | Reiterates | Buy → Buy |
| 06/23/2023 | 267.67% | Canaccord Genuity | → $5 | Reiterates | Buy → Buy |
| 06/07/2023 | 1003.02% | HC Wainwright & Co. | → $15 | Reiterates | Buy → Buy |
| 05/26/2023 | 1003.02% | HC Wainwright & Co. | → $15 | Reiterates | Buy → Buy |
| 05/24/2023 | 561.81% | JonesTrading | → $9 | Initiates Coverage On | → Buy |
| 03/14/2023 | 1003.02% | HC Wainwright & Co. | → $15 | Reiterates | → Buy |
| 03/06/2023 | 267.67% | Canaccord Genuity | $6 → $5 | Maintains | Buy |
| 10/06/2022 | 120.6% | Maxim Group | → $3 | Initiates Coverage On | → Buy |
| 02/17/2021 | 1003.02% | HC Wainwright & Co. | → $15 | Initiates Coverage On | → Buy |
| 05/11/2020 | 341.21% | RBC Capital | $9 → $6 | Maintains | Outperform |
What is the target price for Oncolytics Biotech (ONCY)?
The latest price target for Oncolytics Biotech (NASDAQ: ONCY) was reported by HC Wainwright & Co. on November 13, 2023. The analyst firm set a price target for $5.00 expecting ONCY to rise to within 12 months (a possible 267.67% upside). 9 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Oncolytics Biotech (ONCY)?
The latest analyst rating for Oncolytics Biotech (NASDAQ: ONCY) was provided by HC Wainwright & Co., and Oncolytics Biotech maintained their buy rating.
When is the next analyst rating going to be posted or updated for Oncolytics Biotech (ONCY)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Oncolytics Biotech, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Oncolytics Biotech was filed on November 13, 2023 so you should expect the next rating to be made available sometime around November 13, 2024.
Is the Analyst Rating Oncolytics Biotech (ONCY) correct?
While ratings are subjective and will change, the latest Oncolytics Biotech (ONCY) rating was a maintained with a price target of $15.00 to $5.00. The current price Oncolytics Biotech (ONCY) is trading at is $1.36, which is out of the analyst's predicted range.